[{"id":"idea-prev-glp1-cancer-prevention-rct","kind":"idea","name":"A trial of GLP-1 weight-loss drugs with cancer as the primary outcome","route":"/ideas/idea-prev-glp1-cancer-prevention-rct/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/ideas-waves/wave-prevention.ts","type":"changed","fields":[{"field":"test","before":"\"20,000-person RCT or pooled analysis of cardiovascular outcome trials with prospective cancer adjudication.\"","after":"\"Run a 20,000-person RCT or a pooled analysis of cardiovascular outcome trials with prospective cancer adjudication.\""}]},{"id":"idea-prev-glp1-cancer-prevention-rct","kind":"idea","name":"A trial of GLP-1 weight-loss drugs with cancer as the primary outcome","route":"/ideas/idea-prev-glp1-cancer-prevention-rct/","commit":"6c527727af","date":"2026-09-08","author":"Jude Gomila","message":"Ideas wave: prevention and early detection","file":"src/data/ideas-waves/wave-prevention.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"maturity"},{"field":"actor"},{"field":"cost"},{"field":"horizonYears"},{"field":"bottlenecks"},{"field":"tldr"},{"field":"summary"},{"field":"hypothesis"},{"field":"rationale"},{"field":"test"},{"field":"sections"},{"field":"cancers"},{"field":"companies"},{"field":"technologies"}]}]